EFFICACY AND SAFETY OF DENOSUMAB VS. RISEDRONATE IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE: RESULTS FROM A RANDOMIZED OPEN-LABEL STUDY

Lorenz C Hofbauer, Astrid Fahrleitner-Pammer, Pei-Ran Ho, Federico Hawkins, Christian Roux, Manuela Micaelo, Salvatore Minisola, Nikolaos A Papaioannou, Michael Stone, John Wark, M Carola Zillikens, Irene Ferreira, Suresh Siddhanti, Rachel B Wagman, Jacques P Brown